Utilizing the dTAG system to degrade LSD1 and CRISPR-Cas9 to edit and KO LSD1, findings presented here highlight gene-expression perturbations that lead to differentiation of AML and post-MPN sAML blasts. This evidence concerns the gene KDM1A and acute myeloid leukemia.